Reuters -- Boston Scientific Corp plans to shift resources into research that will help it broaden its product portfolio beyond heart stents and defibrillators, its chief executive said on Tuesday.
Reuters -- Boston Scientific Corp plans to shift resources into research that will help it broaden its product portfolio beyond heart stents and defibrillators, its chief executive said on Tuesday.
